AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Update

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 155,500 shares, a decrease of 58.3% from the March 31st total of 372,800 shares. Approximately 4.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 946,200 shares, the days-to-cover ratio is currently 0.2 days.

Institutional Investors Weigh In On AquaBounty Technologies

An institutional investor recently raised its position in AquaBounty Technologies stock. Epiq Partners LLC boosted its holdings in AquaBounty Technologies, Inc. (NASDAQ:AQB) by 423.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 89,000 shares of the company’s stock after purchasing an additional 72,000 shares during the quarter. Epiq Partners LLC owned approximately 2.30% of AquaBounty Technologies worth $56,000 as of its most recent filing with the Securities and Exchange Commission. 8.92% of the stock is owned by institutional investors and hedge funds.

AquaBounty Technologies Price Performance

Shares of NASDAQ:AQB opened at $0.65 on Tuesday. The business’s fifty day moving average price is $0.66 and its two-hundred day moving average price is $0.80. The stock has a market cap of $2.50 million, a PE ratio of -0.03 and a beta of 1.27. The company has a debt-to-equity ratio of 0.05, a quick ratio of 2.98 and a current ratio of 3.02. AquaBounty Technologies has a one year low of $0.47 and a one year high of $2.17.

About AquaBounty Technologies

AquaBounty Technologies, Inc, a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts.